Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
Marta Sanz Murillo, Amalia Villagran Suarez, Verena Dederer, et al.
Science Advances (2023) Vol. 9, Iss. 48
Open Access | Times Cited: 19

Showing 19 citing articles:

Leucine-Rich Repeat Kinases
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM
Hanwen Zhu, Patricia Hixson, Wen Ma, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
Fengling Li, Suzanne Ackloo, C.H. Arrowsmith, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 22, pp. 8521-8536
Open Access | Times Cited: 7
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
Lijun Dai, Miao Liu, Ke Wei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Network Analysis Performed on Transcriptomes of Parkinson’s Disease Patients Reveals Dysfunction in Protein Translation
Simone D’Angiolini, Maria Lui, Emanuela Mazzon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1299-1299
Open Access | Times Cited: 2
CACHE Challenge #1: targeting the WDR domain of LRRK2, a Parkinson's Disease associated protein.
Fengling Li, Suzanne Ackloo, C.H. Arrowsmith, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Role of the LRRK2 C-terminal tail in domain crosstalk
Pallavi Kaila Sharma, Jui-Hung Weng, Jascha T. Manschwetus, et al.
Biochemical Journal (2024) Vol. 481, Iss. 4, pp. 313-327
Open Access | Times Cited: 1
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons
Chuyu Chen, Meghan Masotti, Nathaniel Shepard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Verena Dederer, Marta Sanz Murillo, Eva Karasmanis, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107469-107469
Open Access | Times Cited: 1
Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez, Antonio Jesús Lara Ordóñez, Patricia Melnyk, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 773-788
Closed Access | Times Cited: 1
Unlocking the potential: unveiling tyrphostins with Michael-reactive cyanoacrylate motif as promising inhibitors of human 5-lipoxygenase
Maximilian Molitor, Amelie Menge, Sebastian Mandel, et al.
Pflügers Archiv - European Journal of Physiology (2024)
Open Access | Times Cited: 1
Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2
Siyu Chen, Tamar Basiashvili, Joshua Hutchings, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of novel LRRK2 inhibitors by structure-based virtual screening and alchemical free energy calculation
Shuoyan Tan, Xiaoqing Gong, Huanxiang Liu, et al.
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 29, pp. 19775-19786
Closed Access
Discovery of potent LRRK2 inhibitors by ensemble virtual screening strategy and bioactivity evaluation
Xiaoqing Gong, Shuli Li, Junli Huang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116812-116812
Closed Access
Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2
Siyu Chen, Tamar Basiashvili, Joshua Hutchings, et al.
(2024)
Open Access
Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2
Siyu Chen, Tamar Basiashvili, Joshua Hutchings, et al.
(2024)
Open Access
Latent allosteric control of protein interactions by ATP-competitive kinase inhibitors
David Vaisar, Natalie G. Ahn
Current Opinion in Structural Biology (2024) Vol. 89, pp. 102935-102935
Closed Access
14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state
Juliana A. Martinez Fiesco, Ning Li, Arthur Adelino de Freitas Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson’s disease
Xiaoxue Bai, Jiawei Zhu, Yao Chen, et al.
Future Medicinal Chemistry (2024), pp. 1-16
Closed Access
Page 1

Scroll to top